Asia IPO round-up: HK, US and India listings coming up

Rashmi Kumar

November 04, 2019 06:15 am

NYSE_stocks__PA_230x150 — (190712) -- NEW YORK, July 12, 2019 (Xinhua) -- Electronic screen shows the closing numbers at the New York Stock Exchange in New York, the United States, July 11, 2019. U.S. stocks ended mixed on Thursday, as investors digested a batch of key data. The market also continued to be encouraged by greater hopes for future rate cuts following the U.S. Federal Reserve chairman's monetary policy testimony. The Dow Jones Industrial Average was up 227.88 points, or 0.85 percent, to 27,088.08. The S&P 500 rose 6.84 points, or 0.23 percent, to 2,999.91. The Nasdaq Composite Index dropped 6.49 points, or 0.08 percent, to 8,196.04. (Xinhua/Wang Ying) | Wang Ying/Xinhua News Agency/PA Images

Shanghai Fosun Pharmaceutical Group, which bought Indian company Gland Pharma in 2016, is planning to list the subsidiary on the National Stock Exchange of India and the BSE.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Deutsche Bank Credit Suisse Equity IPOs UBS Equity China Americas Hong Kong SAR Asia Greater China Haitong Securities Northeast Asia Asia Pacific North America DBS Morgan Stanley BNP Paribas United States Emerging Markets

RK

Rashmi Kumar